Mangalam Drugs & Organics Limited (MANGALAM.BO)
INR 75.87
(4.16%)
INR 75.87
(4.16%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.23 Billion INR | -10.06% |
| 2022 | 1.37 Billion INR | 17.39% |
| 2021 | 1.17 Billion INR | 99.88% |
| 2020 | 585.87 Million INR | -9.65% |
| 2019 | 648.42 Million INR | -11.72% |
| 2018 | 734.53 Million INR | 22.15% |
| 2017 | 601.34 Million INR | 61.44% |
| 2016 | 372.49 Million INR | -21.32% |
| 2015 | 473.4 Million INR | -17.44% |
| 2014 | 573.4 Million INR | 57.19% |
| 2013 | 364.77 Million INR | 17.44% |
| 2012 | 310.59 Million INR | -36.59% |
| 2011 | 489.84 Million INR | 47.23% |
| 2010 | 332.7 Million INR | 39.43% |
| 2009 | 238.61 Million INR | 34.79% |
| 2008 | 177.02 Million INR | 2.42% |
| 2007 | 172.84 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 1.23 Billion INR | -10.06% |
| 2023 Q4 | 1.23 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.4 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 1.37 Billion INR | 17.39% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 1.37 Billion INR | 0.0% |
| 2022 Q2 | 1.4 Billion INR | 0.0% |
| 2021 Q4 | 1.17 Billion INR | 0.0% |
| 2021 FY | 1.17 Billion INR | 99.88% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 1.13 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 585.87 Million INR | 0.0% |
| 2020 FY | 585.87 Million INR | -9.65% |
| 2020 Q2 | 717.56 Million INR | 0.0% |
| 2019 Q4 | 648.42 Million INR | 0.0% |
| 2019 FY | 648.42 Million INR | -11.72% |
| 2019 Q2 | 639.11 Million INR | 0.0% |
| 2018 FY | 734.53 Million INR | 22.15% |
| 2018 Q4 | 734.53 Million INR | 0.0% |
| 2018 Q2 | 753.06 Million INR | 0.0% |
| 2017 Q2 | 577.92 Million INR | 0.0% |
| 2017 FY | 601.34 Million INR | 61.44% |
| 2017 Q4 | 601.34 Million INR | 0.0% |
| 2016 Q4 | 372.49 Million INR | 0.0% |
| 2016 FY | 372.49 Million INR | -21.32% |
| 2016 Q2 | 604.08 Million INR | 0.0% |
| 2015 Q4 | 473.4 Million INR | 0.0% |
| 2015 FY | 473.4 Million INR | -17.44% |
| 2015 Q2 | 644.97 Million INR | 0.0% |
| 2014 Q2 | 354.57 Million INR | 0.0% |
| 2014 Q4 | 573.4 Million INR | 0.0% |
| 2014 FY | 573.4 Million INR | 57.19% |
| 2013 Q4 | 364.77 Million INR | 0.0% |
| 2013 FY | 364.77 Million INR | 17.44% |
| 2013 Q2 | 267.82 Million INR | 0.0% |
| 2012 Q4 | 310.59 Million INR | 0.0% |
| 2012 FY | 310.59 Million INR | -36.59% |
| 2011 Q4 | 489.84 Million INR | 0.0% |
| 2011 FY | 489.84 Million INR | 47.23% |
| 2010 FY | 332.7 Million INR | 39.43% |
| 2009 FY | 238.61 Million INR | 34.79% |
| 2008 FY | 177.02 Million INR | 2.42% |
| 2007 FY | 172.84 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 92.477% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 98.739% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 81.452% |
| Granules India Limited | 13 Billion INR | 90.493% |
| Indoco Remedies Limited | 3.53 Billion INR | 64.981% |
| Achyut Healthcare Limited | 568 Thousand INR | -217575.704% |
| Ajanta Pharma Limited | 8.28 Billion INR | 85.074% |
| Alkem Laboratories Limited | 26.61 Billion INR | 95.354% |
| Alpa Laboratories Limited | 136.65 Million INR | -804.772% |
| Brooks Laboratories Limited | 96.1 Million INR | -1186.467% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 45.744% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 14.162% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -4.384% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 98.055% |
| Eris Lifesciences Limited | 1.89 Billion INR | 34.593% |
| FDC Limited | 3.88 Billion INR | 68.207% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 95.08% |
| Gufic Biosciences Limited | 2 Billion INR | 38.329% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -1082.285% |
| Ipca Laboratories Limited | 24.71 Billion INR | 94.997% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -724.43% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -1162.094% |
| Lasa Supergenerics Limited | 190.43 Million INR | -549.253% |
| Laurus Labs Limited | 18.45 Billion INR | 93.3% |
| Lupin Limited | 49.53 Billion INR | 97.504% |
| Mankind Pharma Limited | 15.53 Billion INR | 92.041% |
| Medicamen Biotech Limited | 593.75 Million INR | -108.235% |
| Medico Remedies Limited | 163.37 Million INR | -656.799% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | 82.35% |
| Piramal Pharma Limited | 21.75 Billion INR | 94.318% |
| RPG Life Sciences Limited | 1.01 Billion INR | -22.416% |
| Sigachi Industries Limited | 707.2 Million INR | -74.828% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 98.747% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 46.522% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -486.485% |
| Unichem Laboratories Limited | 7.04 Billion INR | 82.454% |
| Wanbury Limited | 360.23 Million INR | -243.223% |
| Windlas Biotech Limited | 621.89 Million INR | -98.813% |
| ZIM Laboratories Limited | 812.62 Million INR | -52.148% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 96.408% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 96.117% |
| Hester Biosciences Limited | 755.81 Million INR | -63.586% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -13.317% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -327.75% |
| Bal Pharma Limited | 878.11 Million INR | -40.802% |
| Strides Pharma Science Limited | 11.26 Billion INR | 89.022% |
| Venus Remedies Limited | 1.21 Billion INR | -1.602% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 80.767% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 82.565% |
| Shilpa Medicare Limited | 3.44 Billion INR | 64.155% |
| Aarti Drugs Limited | 4.85 Billion INR | 74.554% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 70.897% |
| Suven Life Sciences Limited | 7.08 Million INR | -17350.924% |
| Ind-Swift Limited | 640.91 Million INR | -92.911% |
| Valiant Laboratories Limited | 100.15 Million INR | -1134.497% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 75.396% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 65.627% |
| Themis Medicare Limited | 705.74 Million INR | -75.191% |
| Hikal Limited | 3.03 Billion INR | 59.292% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 94.575% |
| Sequent Scientific Limited | 3.46 Billion INR | 64.29% |
| Novartis India Limited | 448.6 Million INR | -175.613% |
| Wockhardt Limited | 6.4 Billion INR | 80.681% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 90.413% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -4749.19% |
| Neuland Laboratories Limited | 3.5 Billion INR | 64.717% |
| Morepen Laboratories Limited | 2.48 Billion INR | 50.264% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -3000.296% |